ANNAPOLIS, MD - The Plasma Protein Therapeutics Association (PPTA) applauds Congress and President Obama for preserving patient access to safe and effective plasma protein therapies by repealing the 1099 tax-reporting provision.
ANNAPOLIS, MD – The Plasma Protein Therapeutics Association (PPTA) recently updated the Association's global website and its website on plasma donation with Spanish language translations of some materials posted online to better serve consumers.
PPTA collaborated with the patient community March 31 to host a Congressional staff briefing that focused on the uniqueness of plasma protein therapies; how they are made; the rare, chronic diseases they treat; and the importance of access.
Statements in the international media have described the events resulting from the retraction by several leading medical journals of a large number of articles describing scientific studies by a German physician, Joachim Boldt. Boldt was dismissed from his position as head of anesthesia in the Klinikum Ludwigshafen in the state of Rheinland-Pfalz in Germany in November 2010, following initial findings by a leading anesthesia journal that a paper describing a clinical study which Boldt published in the journal had been fabricated.
